X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE WYETH LTD TTK HEALTHCARE/
WYETH LTD
 
P/E (TTM) x 50.7 27.7 183.0% View Chart
P/BV x 9.3 5.3 174.6% View Chart
Dividend Yield % 0.3 1.3 24.4%  

Financials

 TTK HEALTHCARE   WYETH LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
WYETH LTD
Mar-13
TTK HEALTHCARE/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs6631,044 63.5%   
Low Rs399818 48.8%   
Sales per share (Unadj.) Rs535.6298.6 179.4%  
Earnings per share (Unadj.) Rs15.957.2 27.9%  
Cash flow per share (Unadj.) Rs20.058.4 34.3%  
Dividends per share (Unadj.) Rs4.0017.00 23.5%  
Dividend yield (eoy) %0.81.8 41.2%  
Book value per share (Unadj.) Rs137.6249.5 55.2%  
Shares outstanding (eoy) m7.7722.72 34.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.1 31.8%   
Avg P/E ratio x33.316.3 204.8%  
P/CF ratio (eoy) x26.515.9 166.4%  
Price / Book Value ratio x3.93.7 103.4%  
Dividend payout %25.129.7 84.5%   
Avg Mkt Cap Rs m4,12721,157 19.5%   
No. of employees `0001.70.5 347.2%   
Total wages/salary Rs m607400 151.7%   
Avg. sales/employee Rs Th2,436.713,787.4 17.7%   
Avg. wages/employee Rs Th355.2813.0 43.7%   
Avg. net profit/employee Rs Th72.52,643.3 2.7%   
INCOME DATA
Net Sales Rs m4,1626,783 61.4%  
Other income Rs m61353 17.4%   
Total revenues Rs m4,2237,136 59.2%   
Gross profit Rs m1971,617 12.2%  
Depreciation Rs m3227 119.2%   
Interest Rs m306 543.6%   
Profit before tax Rs m1971,938 10.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m73632 11.5%   
Profit after tax Rs m1241,301 9.5%  
Gross profit margin %4.723.8 19.9%  
Effective tax rate %37.032.6 113.4%   
Net profit margin %3.019.2 15.5%  
BALANCE SHEET DATA
Current assets Rs m1,6296,984 23.3%   
Current liabilities Rs m1,0582,056 51.5%   
Net working cap to sales %13.772.6 18.9%  
Current ratio x1.53.4 45.3%  
Inventory Days Days3099 30.0%  
Debtors Days Days3424 140.3%  
Net fixed assets Rs m556244 227.7%   
Share capital Rs m78227 34.2%   
"Free" reserves Rs m8785,441 16.1%   
Net worth Rs m1,0695,668 18.9%   
Long term debt Rs m15925 634.8%   
Total assets Rs m2,3997,901 30.4%  
Interest coverage x7.6353.3 2.1%   
Debt to equity ratio x0.10 3,364.9%  
Sales to assets ratio x1.70.9 202.0%   
Return on assets %6.416.5 38.8%  
Return on equity %11.622.9 50.5%  
Return on capital %18.534.0 54.2%  
Exports to sales %0.80.2 362.3%   
Imports to sales %1.436.3 3.9%   
Exports (fob) Rs m3315 222.3%   
Imports (cif) Rs m582,465 2.4%   
Fx inflow Rs m3315 216.4%   
Fx outflow Rs m632,677 2.4%   
Net fx Rs m-30-2,662 1.1%   
CASH FLOW
From Operations Rs m127923 13.7%  
From Investments Rs m-146317 -46.1%  
From Financial Activity Rs m22-481 -4.6%  
Net Cashflow Rs m3759 0.3%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 3.7 11.3 32.7%  
FIIs % 5.2 7.2 72.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 30.4 84.9%  
Shareholders   12,723 21,978 57.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SHASUN PHARMA  CIPLA  ABBOTT INDIA  UNICHEM LAB  DR. REDDYS LAB  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 22, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - LUPIN LTD COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS